FOR PHYSICIANS

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients with Atrial Fibrillation (COHERENT–AF)

ClinicalTrials.gov ID NCT06784466

COHERENT–AF is a prospective, multi-center, non-randomized, unblinded pre-market study designed to provide clinical data to support the regulatory approval of the Argá Medtech CSE Ablation System for the ablation of atrial fibrillation and adjunctive use for ablation of typical atrial flutter.

Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients with Atrial Fibrillation (BURST–AF)

ClinicalTrials.gov ID NCT05572047

BURST–AF is a prospective, single-arm, multi-national, non-randomized study designed to provide clinical data to support the use of the Argá Medtech System in the ablation of atrial fibrillation.

More information at ClinicalTrials.gov